ENAMINE Ltd. Company Profile
Enamine is one of the top providers of custom chemistry services and screening libraries for pre-clinical drug discovery and agro chemistry worldwide. Currently Enamine offers its customers one of the largest and the most chemically diverse proprietary screening collection of small organic compounds in the world: • Over 500,000 Screening Compounds in-stock;
• 15,000 proprietary and 9,000 acquired Building Blocks;
• Validated virtual chemical space (REAL Database) of over 12 million compounds
Enamine has earned a reputation as a leading provider of a number of chemistry services, including custom synthesis and lead-oriented services. Keeping close ties with Ukrainian academic research centers, Enamine explores a variety of prospective topics in contemporary organic chemistry, such as assymmetric synthesis, synthesis of fluorescent dyes and peptidomimetics, and supports other projects aimed at the development of fundamental research in organic chemistry. Our Molecular Modeling department is capable of performing complex computation tasks associated with computer aided drug design, from ADME properties prediction and database profiling to lead optimization and designing focused and targeted libraries for a variety of biologically significant targets.
At Enamine, we are committed to providing Life Science industries with a full spectrum of hit-to-lead discovery services. Enamine's competitive pricing policy, top-level customer support and highest quality standards made it a promising partner for your outsourcing tasks.
23 Alexandra Matrosova Street
Phone: 380 44 537 32 18
Fax: 380 44 537 32 53
Enamine Ltd, a leading provider of screening compounds, chemical building blocks and discovery services, and Exquiron Biotech AG, a company specializing in early stage drug discov...
CLEVELAND, Oct. 15, 2012 /PRNewswire/ -- ChanTest, the industry leading ion channel Contract Research Organization (CRO) announces today the addition of a 50,000 compound chemical library from Enamine...
Drugs and Medications
The transition state models in two mechanistically distinct pathways, involving (i) an enamine carboxylic acid (path-A, 4) and (ii) an enamine carboxylate (path-B, 8), in the proline-catalyzed asymmet...
Enamine protonation: A chiral diamine catalyzes an asymmetric Friedel-Crafts reaction through catalytic enantioselective protonation of an enamine. This process can be applied to a range of α-substit...
Synthetic methods for 3-azabicyclo[3.1.0]hex-2-enes and 4-carbonylpyrroles have been developed that use copper-mediated/catalyzed reactions of N-allyl/propargyl enamine carboxylates under an O(2) atmo...
Enamine key intermediates in organocatalysis, derived from aldehydes and prolinol or Jørgensen-Hayashi-type prolinol ether catalysts, were generated in different solvents and investigated by NMR spec...
As part of our ongoing studies to provide an experimental basis for the improved understanding of organocatalytic reaction mechanisms we present a study on the influence of amine bases on enamine inte...
Enamine is a diversified provider of discovery chemistry for pharmaceutical and agrochemical industry needs. The main line of the company activity is organic compound synthesis for screening. Besides...
Enamine is one of the top providers of custom chemistry services and screening libraries for pre-clinical drug discovery and agro chemistry worldwide. Currently Enamine offers its customers one of the...
More Information about "ENAMINE Ltd." on BioPortfolio
We have published hundreds of ENAMINE Ltd. news stories on BioPortfolio along with dozens of ENAMINE Ltd. Clinical Trials and PubMed Articles about ENAMINE Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ENAMINE Ltd. Companies in our database. You can also find out about relevant ENAMINE Ltd. Drugs and Medications on this site too.